Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Mimedx (MDXG) over the last 6 years, with Q3 2025 value amounting to $21.6 million.

  • Mimedx's Long-Term Deferred Tax fell 2934.13% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year decrease of 2934.13%. This contributed to the annual value of $28.3 million for FY2024, which is 3058.34% down from last year.
  • According to the latest figures from Q3 2025, Mimedx's Long-Term Deferred Tax is $21.6 million, which was down 2934.13% from $27.4 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Long-Term Deferred Tax peaked at $40.8 million during Q4 2023, and registered a low of $21.6 million during Q3 2025.
  • In the last 3 years, Mimedx's Long-Term Deferred Tax had a median value of $29.5 million in 2024 and averaged $31.1 million.
  • In the last 5 years, Mimedx's Long-Term Deferred Tax crashed by 3058.34% in 2024 and then plummeted by 1807.36% in 2025.
  • Quarter analysis of 3 years shows Mimedx's Long-Term Deferred Tax stood at $40.8 million in 2023, then plummeted by 30.58% to $28.3 million in 2024, then dropped by 23.53% to $21.6 million in 2025.
  • Its Long-Term Deferred Tax stands at $21.6 million for Q3 2025, versus $27.4 million for Q2 2025 and $27.7 million for Q1 2025.